How did an office clerk become CEO of a major pharmaceutical company? What's "Project Prometheus"? And what's next in drug R&D?
Allison, Adam, and Elaine are asking those questions live from the J.P. Morgan Healthcare Conference in San Francisco.
Then, ARCH Venture Partners co-founder and managing director Bob Nelsen takes the mic to discuss everything going on in D.C., China's ascent in biomedical innovation, and the use of AI in biotech.
New Novo Nordisk CEO Mike Doustdar joins the podcast hosts live to discuss his first few months on the job and the company's push to regain market share in the competitive obesity market.
LISTEN NOW
Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode
Visit the archive to see past episodes
No comments